Latest News and Press Releases

Press release, Helsinki, 2 April 2020 at 9.30 am (EEST) Nexstim Receives New NBS System Order from a Large Hospital in the US Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces...

Press release, Helsinki, 26 March 2020 at 9.30 am (EET) Nexstim Receives Two New NBS System Orders in the United States Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it...

Press Release, Helsinki, 20 August 2019 at 10.00 am (EET) Nexstim reports good initial results on the use of Smartfocus® technology in treatment of major depressive disorder Nexstim Plc...

Pressmeddelande, Helsingfors 16 augusti 2019 kl. 9.00 Viktiga händelser januari–juni 2019 Fokusering på terapistrategi för depressionsbehandling. God framgång genom åtta nya NBT®-system som tagits i...

Yhtiötiedote, Helsinki, 16.8.2019 klo 9.00 Kohokohdat tammi-kesäkuussa 2019 Keskittyminen masennuksen hoitoa toteuttavaan terapiastrategian. Hyvä edistyminen asentamalla klinikoille kahdeksan uutta...

Company announcement, Helsinki, 16 August 2019 at 9:00 am Highlights, January – June 2019 Focused on executing our depression-led therapy strategy. Good progress with a total of eight new NBT®...

Press release, Helsinki, 15 August 2019 at 3.00 pm (EET) Nexstim strengthens foothold in Florida with two additional NBT® system installations Nexstim Plc (NXTMH:HEX, NXTMS:STO) - the targeted...

Pressmeddelande, Helsingfors den 12 augusti 2019 kl. 9.00 (EEST) Nexstim Abp (NXTMH:HEX, NXTMS:STO) (”Nexstim” eller ”bolaget”), ett företag inom riktad neuromodulering som tagit fram och marknadsför...

Yhtiötiedote, Helsinki, 12.8.2019 klo 9.00 (EEST) Nexstim Oyj (NXTMH:HEX, NXTMS:STO) (”Nexstim” tai ”Yhtiö”) on neuromodulaatioyritys, joka on kehittänyt markkinoimansa uraauurtavan kallon...

Company announcement, Helsinki, 12 August 2019 at 9.00 am (EEST) Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), the targeted neuromodulation company developing and marketing pioneering...